Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Diagnostic Tests in Oncology Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Protein Detection
1.2.3 DNA Detection
1.3 Market by Application
1.3.1 Global Companion Diagnostic Tests in Oncology Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Medical Device Companies
1.3.4 Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Companion Diagnostic Tests in Oncology Market Perspective (2018-2033)
2.2 Companion Diagnostic Tests in Oncology Growth Trends by Region
2.2.1 Global Companion Diagnostic Tests in Oncology Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Companion Diagnostic Tests in Oncology Historic Market Size by Region (2018-2023)
2.2.3 Companion Diagnostic Tests in Oncology Forecasted Market Size by Region (2024-2033)
2.3 Companion Diagnostic Tests in Oncology Market Dynamics
2.3.1 Companion Diagnostic Tests in Oncology Industry Trends
2.3.2 Companion Diagnostic Tests in Oncology Market Drivers
2.3.3 Companion Diagnostic Tests in Oncology Market Challenges
2.3.4 Companion Diagnostic Tests in Oncology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Companion Diagnostic Tests in Oncology Players by Revenue
3.1.1 Global Top Companion Diagnostic Tests in Oncology Players by Revenue (2018-2023)
3.1.2 Global Companion Diagnostic Tests in Oncology Revenue Market Share by Players (2018-2023)
3.2 Global Companion Diagnostic Tests in Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Companion Diagnostic Tests in Oncology Revenue
3.4 Global Companion Diagnostic Tests in Oncology Market Concentration Ratio
3.4.1 Global Companion Diagnostic Tests in Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Tests in Oncology Revenue in 2022
3.5 Companion Diagnostic Tests in Oncology Key Players Head office and Area Served
3.6 Key Players Companion Diagnostic Tests in Oncology Product Solution and Service
3.7 Date of Enter into Companion Diagnostic Tests in Oncology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Diagnostic Tests in Oncology Breakdown Data by Type
4.1 Global Companion Diagnostic Tests in Oncology Historic Market Size by Type (2018-2023)
4.2 Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Type (2024-2033)
5 Companion Diagnostic Tests in Oncology Breakdown Data by Application
5.1 Global Companion Diagnostic Tests in Oncology Historic Market Size by Application (2018-2023)
5.2 Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Companion Diagnostic Tests in Oncology Market Size (2018-2033)
6.2 North America Companion Diagnostic Tests in Oncology Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Companion Diagnostic Tests in Oncology Market Size by Country (2018-2023)
6.4 North America Companion Diagnostic Tests in Oncology Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Companion Diagnostic Tests in Oncology Market Size (2018-2033)
7.2 Europe Companion Diagnostic Tests in Oncology Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Companion Diagnostic Tests in Oncology Market Size by Country (2018-2023)
7.4 Europe Companion Diagnostic Tests in Oncology Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size (2018-2033)
8.2 Asia-Pacific Companion Diagnostic Tests in Oncology Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Region (2018-2023)
8.4 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Companion Diagnostic Tests in Oncology Market Size (2018-2033)
9.2 Latin America Companion Diagnostic Tests in Oncology Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Companion Diagnostic Tests in Oncology Market Size by Country (2018-2023)
9.4 Latin America Companion Diagnostic Tests in Oncology Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size (2018-2033)
10.2 Middle East & Africa Companion Diagnostic Tests in Oncology Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Country (2018-2023)
10.4 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Companion Diagnostic Tests in Oncology Introduction
11.1.4 Abbott Revenue in Companion Diagnostic Tests in Oncology Business (2018-2023)
11.1.5 Abbott Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Companion Diagnostic Tests in Oncology Introduction
11.2.4 Roche Revenue in Companion Diagnostic Tests in Oncology Business (2018-2023)
11.2.5 Roche Recent Development
11.3 Genomic Health
11.3.1 Genomic Health Company Detail
11.3.2 Genomic Health Business Overview
11.3.3 Genomic Health Companion Diagnostic Tests in Oncology Introduction
11.3.4 Genomic Health Revenue in Companion Diagnostic Tests in Oncology Business (2018-2023)
11.3.5 Genomic Health Recent Development
11.4 QIAGEN
11.4.1 QIAGEN Company Detail
11.4.2 QIAGEN Business Overview
11.4.3 QIAGEN Companion Diagnostic Tests in Oncology Introduction
11.4.4 QIAGEN Revenue in Companion Diagnostic Tests in Oncology Business (2018-2023)
11.4.5 QIAGEN Recent Development
11.5 Agilent
11.5.1 Agilent Company Detail
11.5.2 Agilent Business Overview
11.5.3 Agilent Companion Diagnostic Tests in Oncology Introduction
11.5.4 Agilent Revenue in Companion Diagnostic Tests in Oncology Business (2018-2023)
11.5.5 Agilent Recent Development
11.6 Agendia
11.6.1 Agendia Company Detail
11.6.2 Agendia Business Overview
11.6.3 Agendia Companion Diagnostic Tests in Oncology Introduction
11.6.4 Agendia Revenue in Companion Diagnostic Tests in Oncology Business (2018-2023)
11.6.5 Agendia Recent Development
11.7 BioMerieux
11.7.1 BioMerieux Company Detail
11.7.2 BioMerieux Business Overview
11.7.3 BioMerieux Companion Diagnostic Tests in Oncology Introduction
11.7.4 BioMerieux Revenue in Companion Diagnostic Tests in Oncology Business (2018-2023)
11.7.5 BioMerieux Recent Development
11.8 Illumina
11.8.1 Illumina Company Detail
11.8.2 Illumina Business Overview
11.8.3 Illumina Companion Diagnostic Tests in Oncology Introduction
11.8.4 Illumina Revenue in Companion Diagnostic Tests in Oncology Business (2018-2023)
11.8.5 Illumina Recent Development
11.9 Siemens Healthcare
11.9.1 Siemens Healthcare Company Detail
11.9.2 Siemens Healthcare Business Overview
11.9.3 Siemens Healthcare Companion Diagnostic Tests in Oncology Introduction
11.9.4 Siemens Healthcare Revenue in Companion Diagnostic Tests in Oncology Business (2018-2023)
11.9.5 Siemens Healthcare Recent Development
11.10 Thermo Fisher
11.10.1 Thermo Fisher Company Detail
11.10.2 Thermo Fisher Business Overview
11.10.3 Thermo Fisher Companion Diagnostic Tests in Oncology Introduction
11.10.4 Thermo Fisher Revenue in Companion Diagnostic Tests in Oncology Business (2018-2023)
11.10.5 Thermo Fisher Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Companion Diagnostic Tests in Oncology Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Protein Detection
Table 3. Key Players of DNA Detection
Table 4. Global Companion Diagnostic Tests in Oncology Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Companion Diagnostic Tests in Oncology Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Companion Diagnostic Tests in Oncology Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Companion Diagnostic Tests in Oncology Market Share by Region (2018-2023)
Table 8. Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Companion Diagnostic Tests in Oncology Market Share by Region (2024-2033)
Table 10. Companion Diagnostic Tests in Oncology Market Trends
Table 11. Companion Diagnostic Tests in Oncology Market Drivers
Table 12. Companion Diagnostic Tests in Oncology Market Challenges
Table 13. Companion Diagnostic Tests in Oncology Market Restraints
Table 14. Global Companion Diagnostic Tests in Oncology Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Companion Diagnostic Tests in Oncology Market Share by Players (2018-2023)
Table 16. Global Top Companion Diagnostic Tests in Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic Tests in Oncology as of 2022)
Table 17. Ranking of Global Top Companion Diagnostic Tests in Oncology Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Companion Diagnostic Tests in Oncology Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Companion Diagnostic Tests in Oncology Product Solution and Service
Table 21. Date of Enter into Companion Diagnostic Tests in Oncology Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Companion Diagnostic Tests in Oncology Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Type (2018-2023)
Table 25. Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Type (2024-2033)
Table 27. Global Companion Diagnostic Tests in Oncology Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Application (2018-2023)
Table 29. Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Application (2024-2033)
Table 31. North America Companion Diagnostic Tests in Oncology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Companion Diagnostic Tests in Oncology Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Companion Diagnostic Tests in Oncology Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Companion Diagnostic Tests in Oncology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Companion Diagnostic Tests in Oncology Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Companion Diagnostic Tests in Oncology Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Companion Diagnostic Tests in Oncology Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Companion Diagnostic Tests in Oncology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Companion Diagnostic Tests in Oncology Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Companion Diagnostic Tests in Oncology Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Country (2024-2033) & (US$ Million)
Table 46. Abbott Company Detail
Table 47. Abbott Business Overview
Table 48. Abbott Companion Diagnostic Tests in Oncology Product
Table 49. Abbott Revenue in Companion Diagnostic Tests in Oncology Business (2018-2023) & (US$ Million)
Table 50. Abbott Recent Development
Table 51. Roche Company Detail
Table 52. Roche Business Overview
Table 53. Roche Companion Diagnostic Tests in Oncology Product
Table 54. Roche Revenue in Companion Diagnostic Tests in Oncology Business (2018-2023) & (US$ Million)
Table 55. Roche Recent Development
Table 56. Genomic Health Company Detail
Table 57. Genomic Health Business Overview
Table 58. Genomic Health Companion Diagnostic Tests in Oncology Product
Table 59. Genomic Health Revenue in Companion Diagnostic Tests in Oncology Business (2018-2023) & (US$ Million)
Table 60. Genomic Health Recent Development
Table 61. QIAGEN Company Detail
Table 62. QIAGEN Business Overview
Table 63. QIAGEN Companion Diagnostic Tests in Oncology Product
Table 64. QIAGEN Revenue in Companion Diagnostic Tests in Oncology Business (2018-2023) & (US$ Million)
Table 65. QIAGEN Recent Development
Table 66. Agilent Company Detail
Table 67. Agilent Business Overview
Table 68. Agilent Companion Diagnostic Tests in Oncology Product
Table 69. Agilent Revenue in Companion Diagnostic Tests in Oncology Business (2018-2023) & (US$ Million)
Table 70. Agilent Recent Development
Table 71. Agendia Company Detail
Table 72. Agendia Business Overview
Table 73. Agendia Companion Diagnostic Tests in Oncology Product
Table 74. Agendia Revenue in Companion Diagnostic Tests in Oncology Business (2018-2023) & (US$ Million)
Table 75. Agendia Recent Development
Table 76. BioMerieux Company Detail
Table 77. BioMerieux Business Overview
Table 78. BioMerieux Companion Diagnostic Tests in Oncology Product
Table 79. BioMerieux Revenue in Companion Diagnostic Tests in Oncology Business (2018-2023) & (US$ Million)
Table 80. BioMerieux Recent Development
Table 81. Illumina Company Detail
Table 82. Illumina Business Overview
Table 83. Illumina Companion Diagnostic Tests in Oncology Product
Table 84. Illumina Revenue in Companion Diagnostic Tests in Oncology Business (2018-2023) & (US$ Million)
Table 85. Illumina Recent Development
Table 86. Siemens Healthcare Company Detail
Table 87. Siemens Healthcare Business Overview
Table 88. Siemens Healthcare Companion Diagnostic Tests in Oncology Product
Table 89. Siemens Healthcare Revenue in Companion Diagnostic Tests in Oncology Business (2018-2023) & (US$ Million)
Table 90. Siemens Healthcare Recent Development
Table 91. Thermo Fisher Company Detail
Table 92. Thermo Fisher Business Overview
Table 93. Thermo Fisher Companion Diagnostic Tests in Oncology Product
Table 94. Thermo Fisher Revenue in Companion Diagnostic Tests in Oncology Business (2018-2023) & (US$ Million)
Table 95. Thermo Fisher Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Companion Diagnostic Tests in Oncology Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Companion Diagnostic Tests in Oncology Market Share by Type: 2022 VS 2033
Figure 3. Protein Detection Features
Figure 4. DNA Detection Features
Figure 5. Global Companion Diagnostic Tests in Oncology Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Companion Diagnostic Tests in Oncology Market Share by Application: 2022 VS 2033
Figure 7. Pharmaceutical & Biotechnology Companies Case Studies
Figure 8. Medical Device Companies Case Studies
Figure 9. Research Institutes Case Studies
Figure 10. Others Case Studies
Figure 11. Companion Diagnostic Tests in Oncology Report Years Considered
Figure 12. Global Companion Diagnostic Tests in Oncology Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Companion Diagnostic Tests in Oncology Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Companion Diagnostic Tests in Oncology Market Share by Region: 2022 VS 2033
Figure 15. Global Companion Diagnostic Tests in Oncology Market Share by Players in 2022
Figure 16. Global Top Companion Diagnostic Tests in Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic Tests in Oncology as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Companion Diagnostic Tests in Oncology Revenue in 2022
Figure 18. North America Companion Diagnostic Tests in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Companion Diagnostic Tests in Oncology Market Share by Country (2018-2033)
Figure 20. United States Companion Diagnostic Tests in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Companion Diagnostic Tests in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Companion Diagnostic Tests in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Companion Diagnostic Tests in Oncology Market Share by Country (2018-2033)
Figure 24. Germany Companion Diagnostic Tests in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Companion Diagnostic Tests in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Companion Diagnostic Tests in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Companion Diagnostic Tests in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Companion Diagnostic Tests in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Companion Diagnostic Tests in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Companion Diagnostic Tests in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Companion Diagnostic Tests in Oncology Market Share by Region (2018-2033)
Figure 32. China Companion Diagnostic Tests in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Companion Diagnostic Tests in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Companion Diagnostic Tests in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Companion Diagnostic Tests in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Companion Diagnostic Tests in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Companion Diagnostic Tests in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Companion Diagnostic Tests in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Companion Diagnostic Tests in Oncology Market Share by Country (2018-2033)
Figure 40. Mexico Companion Diagnostic Tests in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Companion Diagnostic Tests in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Companion Diagnostic Tests in Oncology Market Share by Country (2018-2033)
Figure 44. Turkey Companion Diagnostic Tests in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Companion Diagnostic Tests in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Abbott Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2018-2023)
Figure 47. Roche Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2018-2023)
Figure 48. Genomic Health Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2018-2023)
Figure 49. QIAGEN Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2018-2023)
Figure 50. Agilent Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2018-2023)
Figure 51. Agendia Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2018-2023)
Figure 52. BioMerieux Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2018-2023)
Figure 53. Illumina Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2018-2023)
Figure 54. Siemens Healthcare Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2018-2023)
Figure 55. Thermo Fisher Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed